Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HONEST to clarify association between home blood pressure and cardiovascular events under antihypertensive medication.

× No keyword cloud information.

8 in total

1. Effect of olmesartan on blood pressure in patients with hypertension: specification on causality.

Authors: T Kawada
Journal: J Hum Hypertens Date: 2014-01-23 Impact factor: 3.012

2. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.

Authors: Hisao Ogawa; Shokei Kim-Mitsuyama; Kunihiko Matsui; Tomio Jinnouchi; Hideaki Jinnouchi; Kikuo Arakawa
Journal: Am J Med Date: 2012-04-14 Impact factor: 4.965

3. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.

Authors: David H G Smith; Robert Dubiel; Michael Jones
Journal: Am J Cardiovasc Drugs Date: 2005 Impact factor: 3.571

4. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.

Authors: Yoshio Matsui; Michael F O'Rourke; Satoshi Hoshide; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal: Hypertension Date: 2012-04-30 Impact factor: 10.190

5. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension.

Authors: Hans R Brunner; Klaus O Stumpe; Andrzej Januszewicz
Journal: Clin Drug Investig Date: 2003 Impact factor: 2.859

6. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.

Authors: S Oparil; D Williams; S G Chrysant; T C Marbury; J Neutel
Journal: J Clin Hypertens (Greenwich) Date: 2001 Sep-Oct Impact factor: 3.738

7. Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.

Authors: Ikuo Saito; Kazuomi Kario; Toshio Kushiro; Satoshi Teramukai; Natsuko Zenimura; Katsutoshi Hiramatsu; Fumiaki Kobayashi; Kazuyuki Shimada
Journal: Hypertens Res Date: 2012-10-25 Impact factor: 3.872

8. Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.

Authors: K Kario; I Saito; T Kushiro; S Teramukai; Y Ishikawa; K Hiramatsu; F Kobayashi; K Shimada
Journal: J Hum Hypertens Date: 2013-07-18 Impact factor: 3.012

8 in total